Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1987 Jul;42(7):481–486. doi: 10.1136/thx.42.7.481

Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study.

P Girard 1, M Mathieu 1, G Simonneau 1, P Petitpretz 1, J Cerrina 1, P Herve 1, J Rosso 1, D Musset 1, J Mensch 1, P Duroux 1
PMCID: PMC460799  PMID: 3438891

Abstract

The risk of early recurrence of pulmonary embolism in patients with venous thromboembolic disease treated by anticoagulants is not well established. To determine the risk linked to contemporary proximal deep venous thrombosis, a prospective study was organised to give clinical and scintigraphic surveillance to 50 patients with angiographically proved pulmonary embolism plus phlebographically proved proximal deep vein thrombosis during the first 15 days of anticoagulant treatment. Perfusion lung scans were performed initially and on days 3, 7, and 15. Only two patients had a recurrence of pulmonary embolism during this period; both episodes were revealed by new symptoms, and one recurrence was fatal. The systematic performance of angiography in four patients found to have new scintigraphic defects led to the diagnosis of "spurious scintigraphic recurrence" in three of them. It is concluded that (a) adjusted anticoagulant treatment showed an effectiveness of 96% for preventing early recurrence of pulmonary embolism in this group of supposed high risk patients, and (b) in patients with recent pulmonary embolism new defects on systematic perfusion lung scans are not specific indicators of recurrent pulmonary embolism.

Full text

PDF
481

Images in this article

484Image
on p.484

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARRITT D. W., JORDAN S. C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960 Jun 18;1(7138):1309–1312. doi: 10.1016/s0140-6736(60)92299-6. [DOI] [PubMed] [Google Scholar]
  2. Basu D., Gallus A., Hirsh J., Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med. 1972 Aug 17;287(7):324–327. doi: 10.1056/NEJM197208172870703. [DOI] [PubMed] [Google Scholar]
  3. Bomalaski J. S., Martin G. J., Hughes R. L., Yao J. S. Inferior vena cava interruption in the management of pulmonary embolism. Chest. 1982 Dec;82(6):767–774. doi: 10.1378/chest.82.6.767. [DOI] [PubMed] [Google Scholar]
  4. Casagrande J. T., Pike M. C. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics. 1978 Sep;34(3):483–486. [PubMed] [Google Scholar]
  5. Coon W. W., Willis P. W., 3rd Recurrence of venous thromboembolism. Surgery. 1973 Jun;73(6):823–827. [PubMed] [Google Scholar]
  6. Glazier R. L., Crowell E. B. Randomized prospective trial of continuous vs intermittent heparin therapy. JAMA. 1976 Sep 20;236(12):1365–1367. [PubMed] [Google Scholar]
  7. Hattersley P. G., Mitsuoka J. C., King J. H. Heparin therapy for thromboembolic disorders. A prospective evaluation of 134 cases monitored by the activated coagulation time. JAMA. 1983 Sep 16;250(11):1413–1416. doi: 10.1001/jama.250.11.1413. [DOI] [PubMed] [Google Scholar]
  8. Ly B., Arnesen H., Eie H., Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand. 1978;203(6):465–470. doi: 10.1111/j.0954-6820.1978.tb14909.x. [DOI] [PubMed] [Google Scholar]
  9. Miller G. A., Sutton G. C., Kerr I. H., Gibson R. V., Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J. 1971 Jun 19;2(5763):681–684. doi: 10.1136/bmj.2.5763.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Moser K. M., LeMoine J. R. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med. 1981 Apr;94(4 Pt 1):439–444. doi: 10.7326/0003-4819-94-4-439. [DOI] [PubMed] [Google Scholar]
  11. Moser K. M., Longo A. M., Ashburn W. L., Guisan M. Spurious scintiphotographic recurrence of pulmonary emboli. Am J Med. 1973 Oct;55(3):434–443. doi: 10.1016/0002-9343(73)90200-3. [DOI] [PubMed] [Google Scholar]
  12. Moser K. M. Pulmonary embolism. Am Rev Respir Dis. 1977 May;115(5):829–852. doi: 10.1164/arrd.1977.115.5.829. [DOI] [PubMed] [Google Scholar]
  13. Petitpretz P., Simmoneau G., Cerrina J., Musset D., Dreyfus M., Vandenbroek M. D., Duroux P. Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial. Circulation. 1984 Nov;70(5):861–866. doi: 10.1161/01.cir.70.5.861. [DOI] [PubMed] [Google Scholar]
  14. Pollak E. W., DeNardo S., Pollak M., DeNardo G., Wolfman E. F., Jr Detection of anticoagulation therapy failures in patients with venous thrombosis. Am J Surg. 1977 Aug;134(2):214–216. doi: 10.1016/0002-9610(77)90347-6. [DOI] [PubMed] [Google Scholar]
  15. Salzman E. W., Deykin D., Shapiro R. M., Rosenberg R. Management of heparin therapy: Controlled prospective trial. N Engl J Med. 1975 May 15;292(20):1046–1050. doi: 10.1056/NEJM197505152922002. [DOI] [PubMed] [Google Scholar]
  16. Tibbutt D. A., Davies J. A., Anderson J. A., Fletcher E. W., Hamill J., Holt J. M., Thomas M. L., Lee G., Miller G. A., Sharp A. A. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J. 1974 Mar 2;1(5904):343–347. doi: 10.1136/bmj.1.5904.343. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES